Adiponectin is inversely associated with intramyocellular and intrahepatic lipids in obese premenopausal women

Obesity

Volumn 19, Issue 5, 2011, Pages 911-916

  Bredella, Miriam A ^a   Torriani, Martin ^a   Ghomi, Reza H ^a   Thomas, Bijoy J ^a   Brick, Danielle J ^a   Gerweck, Anu V ^a   Harrington, Lindsey M ^a   Miller, Karen K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLUCOSE; INSULIN; LIPID; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY FAT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIVER; NORMAL HUMAN; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREMENOPAUSE; PROTON NUCLEAR MAGNETIC RESONANCE; SKELETAL MUSCLE;

ABSORPTIOMETRY, PHOTON; ADIPONECTIN; ADOLESCENT; ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUCOSE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LIPID METABOLISM; LIVER; OBESITY; PREMENOPAUSE; TRIGLYCERIDES; YOUNG ADULT;

MUS;

EID: 79955482896     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2010.296     Document Type: Article

References (37)

1. Bugianesi E, Pagotto U, Manini R et al. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J Clin Endocrinol Metab 2005;90:3498-3504. (Pubitemid 41014319)
2. Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression. Diabetes 2003;52:1779-1785. (Pubitemid 36792470)
3. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish H F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995;270:26746-26749.
4. Weyer C, Funahashi T, Tanaka S et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-1935. (Pubitemid 32472900)
5. Heidemann C, Sun Q, van Dam RM et al. Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann Intern Med 2008;149:307-316.
6. Hill MJ, Kumar S, McTernan PG. Adipokines and the clinical laboratory: what to measure, when and how? J Clin Pathol 2009;62:206-211.
7. Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey W T. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes 2006;55:249-259. (Pubitemid 43343322)
8. Yamauchi T, Kamon J, Waki H et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-946. (Pubitemid 32756432)
9. Godoy-Matos A F, Bahia LR, Domingues RC et al. Adiponectin is related to intramyocellular lipid content in nondiabetic adults. J Endocrinol Invest 2010;33:382-387.
10. Koska J, Stefan N, Permana PA et al. Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals. Am J Clin Nutr 2008;87:295-302. (Pubitemid 351226063)
11. Weiss R, Dufour S, Groszmann A et al. Low adiponectin levels in adolescent obesity: a marker of increased intramyocellular lipid accumulation. J Clin Endocrinol Metab 2003;88:2014-2018. (Pubitemid 36549870)
12. Furler SM, Gan SK, Poynten AM et al. Relationship of adiponectin with insulin sensitivity in humans, independent of lipid availability. Obesity (Silver Spring) 2006;14:228-234. (Pubitemid 46214752)
13. Maeda K, Ishihara K, Miyake K et al. Inverse correlation between serum adiponectin concentration and hepatic lipid content in Japanese with type 2 diabetes. Metabolism 2005;54:775-780. (Pubitemid 40725327)
14. Teranishi T, Ohara T, Maeda K et al. Effects of pioglitazone and metformin on intracellular lipid content in liver and skeletal muscle of individuals with type 2 diabetes mellitus. Metabolism 2007;56:1418-1424. (Pubitemid 47404606)
15. Hwang JH, Stein DT, Barzilai N et al. Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies. Am J Physiol Endocrinol Metab 2007;293: E1663-E1669. (Pubitemid 350255117)
16. Bredella MA, Ghomi RH, Thomas BJ, Miller KK, Torriani M. Comparison of 3.0 T proton magnetic resonance spectroscopy short and long echo-time measures of intramyocellular lipids in obese and normal-weight women. J Magn Reson Imaging 2010;32:388-393.
17. Bredella MA, Ghomi RH, Thomas BJ et al. Breath-hold 1H-magnetic resonance spectroscopy for intrahepatic lipid quantification at 3 Tesla. J Comput Assist Tomogr 2010;34:372-376.
18. Bredella MA, Torriani M, Thomas BJ et al. Peak growth hormone-releasing hormone-arginine-stimulated growth hormone is inversely associated with intramyocellular and intrahepatic lipid content in premenopausal women with obesity. J Clin Endocrinol Metab 2009;94:3995-4002.
19. Matthews DR, Hosker J P, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419. (Pubitemid 15018832)
20. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672-679. (Pubitemid 23360802)
21. Borkan GA, Gerzof SG, Robbins AH et al. Assessment of abdominal fat content by computed tomography. Am J Clin Nutr 1982;36:172-177. (Pubitemid 12000247)
22. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000;894:i-xii, 1-253.
23. Rasouli N, Kern PA. Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 2008;93:S64-S73.
24. Berg AH, Combs T P, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 2001;7:947-953. (Pubitemid 32756433)
25. Bajaj M, Suraamornkul S, Piper P et al. Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. J Clin Endocrinol Metab 2004;89:200-206. (Pubitemid 38183882)
26. Hui JM, Hodge A, Farrell GC et al. Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 2004;40:46-54. (Pubitemid 38868922)
27. Thamer C, Machann J, Tschritter O et al. Relationship between serum adiponectin concentration and intramyocellular lipid stores in humans. Horm Metab Res 2002;34:646-649. (Pubitemid 36398700)
28. Ruan H, Lodish HF. Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha. Cytokine Growth Factor Rev 2003;14:447-455. (Pubitemid 37099456)
29. Cook JR, Semple RK. Hypoadiponectinemia-cause or consequence of human "insulin resistance"? J Clin Endocrinol Metab 2010;95:1544-1554.
30. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 2000;106:171-176. (Pubitemid 30483118)
31. Utzschneider KM, Kahn SE. Review: The role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab 2006;91: 4753-4761. (Pubitemid 44917301)
32. Cnop M, Havel PJ, Utzschneider KM et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003;46:459-469. (Pubitemid 36577787)
33. Hanley AJ, Bowden D, Wagenknecht LE et al. Associations of adiponectin with body fat distribution and insulin sensitivity in nondiabetic Hispanics and African-Americans. J Clin Endocrinol Metab 2007;92: 2665-2671. (Pubitemid 47037374)
34. Frederiksen L, Nielsen TL, Wraae K et al. Subcutaneous rather than visceral adipose tissue is associated with adiponectin levels and insulin resistance in young men. J Clin Endocrinol Metab 2009;94:4010-4015.
35. Hara K, Horikoshi M, Yamauchi T et al. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 2006;29: 1357-1362. (Pubitemid 44125935)
36. Wang Y, Lam KS, Yau MH, Xu A. Post-translational modifications of adiponectin: mechanisms and functional implications. Biochem J 2008;409:623-633. (Pubitemid 351214189)
37. Blüher M, Brennan AM, Kelesidis T et al. Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays. Diabetes Care 2007;30:280-285. (Pubitemid 46198331)